{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:57:28Z","timestamp":1793404648168,"version":"4.5.0"},"reference-count":145,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1053\/j.semnuclmed.2013.04.008","type":"journal-article","created":{"date-parts":[[2013,7,29]],"date-time":"2013-07-29T22:31:38Z","timestamp":1375137098000},"page":"349-366","source":"Crossref","is-referenced-by-count":91,"title":["FDG-PET Imaging in HIV Infection and Tuberculosis"],"prefix":"10.1053","volume":"43","author":[{"given":"Mike","family":"Sathekge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe Van de","family":"Wiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2013.04.008_bib1","unstructured":"UNAIDS. Together We Will End AIDS. Geneva, Switzerland: Joint United Nations Programme on HIV\/AIDS (UNAIDS); 2012. http:\/\/www.unaids.org\/en\/resources\/campaigns\/togetherwewillendaids\/"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib2","unstructured":"WHO. Global Tuberculosis Control 2011. Geneva, Switzerland: World Health Organization; 2011. http:\/\/www.who.int\/tb\/publications\/global_report\/2011\/gtbr11_full.pdf"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11904-006-0002-5","article-title":"Decimated or missing in action: CD4+ T cells as targets and effectors in the pathogenesis of primary HIV infection","volume":"3","author":"Kelleher","year":"2006","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF02976619","article-title":"AIDS related opportunistic infections, going but not gone","volume":"25","author":"Samuel","year":"2002","journal-title":"Arch Pharm Res"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0065-230X(08)00409-0","article-title":"HIV induced AIDS and related cancers: Chronic immune activation and future therapeutic strategies","volume":"101","author":"Cadogan","year":"2008","journal-title":"Adv Cancer Res"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1570162043351002","article-title":"Neoplastic conditions in the context of HIV-1 infection","volume":"2","author":"Aoki","year":"2004","journal-title":"Curr HIV Res"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib7","first-page":"223","article-title":"Prevalence of AIDS dementia complex: Results from a state-wide population-based registry of Alzheimer's disease and related disorders","volume":"104","author":"Porter","year":"2008","journal-title":"J S C Med Assoc"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/QCO.0b013e32835ba8f9","article-title":"Antiretroviral therapy during tuberculosis treatment","volume":"26","author":"Naidoo","year":"2013","journal-title":"Curr Opin Infect Dis"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study","volume":"43","author":"Palella","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.aids.0000196178.73174.24","article-title":"Deaths in the era of HAART: Contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers","volume":"20","author":"Sabin","year":"2006","journal-title":"AIDS"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/01.aids.0000216375.99560.a2","article-title":"Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion","volume":"20","author":"Smit","year":"2006","journal-title":"AIDS"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/01.qai.0000179459.31562.16","article-title":"Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras","volume":"41","author":"Crum","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib13","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/QAI.0b013e31817efb54","article-title":"Changes in causes of death among adults infected by HIV between 2000 and 2005: The \u201cMortalit\u00e9 2000 and 2005\u201d surveys (ANRS EN19 and Mortavic)","volume":"48","author":"Lewden","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1080\/00365540510035328","article-title":"Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France","volume":"37","author":"Bonnet","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1468-1293.2005.00271.x","article-title":"Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003","volume":"6","author":"Krentz","year":"2005","journal-title":"HIV Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1468-1293.2008.00600.x","article-title":"Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005","volume":"9","author":"Yang","year":"2008","journal-title":"HIV Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/j.semnuclmed.2004.06.006","article-title":"Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders","volume":"34","author":"El-Haddad","year":"2004","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib18","first-page":"104","article-title":"Microautoradiolgraphic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake","volume":"35","author":"Kubota","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib19","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1200\/JCO.2004.10.160","article-title":"Diagnosis of deep septic thrombophlebitis in cancer patients by fluorine-18 fluorodeoxyglucose positron emission tomography scanning: A preliminary report","volume":"22","author":"Miceli","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib20","doi-asserted-by":"crossref","first-page":"7857","DOI":"10.1200\/JCO.2004.00.8581","article-title":"18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: A study of 165 infectious episodes","volume":"23","author":"Mahfouz","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1357-4310(99)01663-9","article-title":"How does HIV cause AIDS? The homing theory","volume":"6","author":"Cloyd","year":"2000","journal-title":"Mol Med Today"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.smim.2008.06.001","article-title":"The lymph node in HIV pathogenesis","volume":"20","author":"Lederman","year":"2008","journal-title":"Semin Immunol"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib23","first-page":"352","article-title":"Benign causes of 18-FDG uptake on whole-body imaging","volume":"28","author":"Bakheet","year":"2000","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib24","first-page":"1854","article-title":"Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: Are inflammatory cells important?","volume":"36","author":"Brown","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib25","first-page":"1972","article-title":"Intratumoral distribution of fluorine-18-deoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography","volume":"33","author":"Kubota","year":"1992","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/mrm.1910290307","article-title":"Metabolic changes in activated Tcells: An NMR study of human peripheral blood lymphocytes","volume":"29","author":"Bental","year":"1993","journal-title":"Magn Reson Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0014-4827(91)90116-C","article-title":"Expression of glycolytic isoenzymes in activated human peripheral lymphocytes: Cell cycle analysis using flow cytometry","volume":"193","author":"Marjanovic","year":"1991","journal-title":"Exp Cell Res"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib28","first-page":"701","article-title":"Characterization of hilar lymph node by 18F-fluro-2-deoxyglucose positron emission tomography in healthy subjects","volume":"21","author":"Kwan","year":"2001","journal-title":"Anticancer Res"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib29","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1073\/pnas.93.13.6425","article-title":"Whole body positron emission tomography imaging of simian immunodeficiency virus-infected rhesus macaques","volume":"93","author":"Scharko","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/viro.2000.0479","article-title":"Whole body positron emission tomography imaging of activated lymphoid tissues during acute simian-human immunodeficiency virus 89.6PD infection in rhesus macaques","volume":"274","author":"Wallace","year":"2000","journal-title":"Virology"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib31","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(03)14366-8","article-title":"Whole-body positron emission tomography in patients with HIV-1 infection","volume":"20","author":"Scharko","year":"2003","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib32","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(03)14363-2","article-title":"Anatomical loci of HIV-associated immune activation and association with viraemia","volume":"20","author":"Iyengar","year":"2003","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MNM.0b013e3283331114","article-title":"Fluorodeoxyglucose uptake by lymph nodes of HIV patients is inversely related to CD4 cell count","volume":"31","author":"Sathekge","year":"2010","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib34","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/01.aids.0000210603.40267.29","article-title":"Fluorodeoxyglucose imaging in healthy subjects with HIV infection: Impact of disease stage and therapy on pattern of nodal activation","volume":"20","author":"Brust","year":"2006","journal-title":"AIDS"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib35","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/MNM.0b013e32832fa254","article-title":"Clinical significance of diffusely increased splenic uptake on FDG-PET","volume":"30","author":"Liu","year":"2009","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib36","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s00259-008-1023-7","article-title":"FDG-PET imaging in HIV-infected subjects: Relation with therapy and immunovirological variables","volume":"36","author":"Lucignani","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib37","first-page":"35","article-title":"Fever of unknown origin\u2014Reexamined and redefined","volume":"11","author":"Durack","year":"1991","journal-title":"Curr Clin Top Infect Dis"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1365-2796.2003.01120.x","article-title":"Fever of unknown origin in adults: 40 years on","volume":"253","author":"Knockaert","year":"2003","journal-title":"J Intern Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-125-4-199608150-00001","article-title":"Clinical and epidemiologic features of primary HIV infection","volume":"125","author":"Schacker","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib40","first-page":"276","article-title":"Fever in HIV-infected patients: Less frequent but still complex","volume":"67","author":"De Munter","year":"2012","journal-title":"Acta Clin Belg"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1023\/A:1008617019897","article-title":"Managing drug reactions to sulfonamides and other drugs in HIV infection: Desensitization rather than rechallenge?","volume":"20","author":"Koopmans","year":"1998","journal-title":"Pharm World Sci"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib42","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archpsyc.58.8.721","article-title":"Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States","volume":"58","author":"Bing","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.semnuclmed.2008.10.002","article-title":"Fever of unknown origin","volume":"39","author":"Bleeker-Rovers","year":"2009","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib44","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.2967\/jnumed.108.054692","article-title":"Fever of unknown origin: The role of 18F-FDGPET\/CT","volume":"49","author":"Keidar","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib45","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1007\/s00259-010-1587-x","article-title":"FDG-PET\/CT in infections: The imaging method of choice?","volume":"37","author":"Glaudemans","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"suppl 4","key":"10.1053\/j.semnuclmed.2013.04.008_bib46","doi-asserted-by":"crossref","first-page":"18107","DOI":"10.7448\/IAS.15.6.18107","article-title":"Role and interpretation of FDG-PET\/CT in HIV patients with fever of unknown origin: A prospective study","volume":"15","author":"Martin","year":"2012","journal-title":"J Int AIDS Soc"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib47","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/CCO.0b013e32830a5080","article-title":"Evolving epidemiology of malignancies in HIV","volume":"20","author":"Bonnet","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib48","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2008.19.6626","article-title":"Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection","volume":"27","author":"Powles","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: A meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib50","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11904-008-0022-4","article-title":"Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era","volume":"5","author":"Bedimo","year":"2008","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"23","key":"10.1053\/j.semnuclmed.2013.04.008_bib51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/QAD.0b013e328317cc2d","article-title":"Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: A 20-year cohort study","volume":"2","author":"Crum-Cianflone","year":"2009","journal-title":"AIDS"},{"issue":"S2","key":"10.1053\/j.semnuclmed.2013.04.008_bib52","first-page":"189","article-title":"AIDS-defining neoplasm prevalence in a cohort of HIV-infected patients, before and after highly active antiretroviral therapy","volume":"18","author":"Mayor","year":"2008","journal-title":"Ethn Dis"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib53","first-page":"151","article-title":"Cancer and AIDS: Indian","volume":"48","author":"Chitale","year":"2005","journal-title":"J Pathol Microbiol"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib54","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1080\/01443610500294599","article-title":"Invasive cervical cancer and human immunodeficiency virus (HIV) infection in KwaZulu-Natal, South Africa","volume":"25","author":"Moodley","year":"2005","journal-title":"J Obstet Gynecol"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib55","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1158\/1078-0432.CCR-07-5252","article-title":"Intratumoral metabolic heterogeneity of cervical cancer","volume":"14","author":"Kidd","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib56","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/CCO.0b013e32833cff4f","article-title":"Issues in cervical cancer incidence and treatment in HIV","volume":"22","author":"Einstein","year":"2010","journal-title":"Curr Opin Oncol"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib57","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/CCO.0b013e32832ec63f","article-title":"Role of PET in gynecologic malignancy","volume":"21","author":"Grigsby","year":"2009","journal-title":"Curr Opin Oncol"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib58","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ygyno.2012.06.027","article-title":"FDG-PET-based prognostic nomograms for locally advanced cervical cancer","volume":"127","author":"Kidd","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib59","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1097\/00000478-200312000-00007","article-title":"Human herpesvirus-8 latent nuclear antigen-1 expression in endemic Kaposi sarcoma: An immunohistochemical study of 16 cases","volume":"27","author":"Schwartz","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib60","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/01.cco.0000239884.05914.13","article-title":"Signal transduction targets in Kaposi's sarcoma","volume":"18","author":"Sullivan","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib61","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.qco.0000200295.30285.13","article-title":"AIDS-related malignancies: Changing epidemiology and the impact of highly active antiretroviral therapy","volume":"19","author":"Bower","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib62","first-page":"444","article-title":"Imaging of HIV-associated Kaposi sarcoma. F-18-FDG-PET\/CT and In-111-bevacizumabscintigraphy","volume":"54","author":"van de Luijtgaarden","year":"2010","journal-title":"J AIDS"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib63","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s11604-010-0481-6","article-title":"Whole-body 18F-fluorodeoxyglucose positron emission tomography\/computed tomography images before and after chemotherapy for Kaposi sarcoma and highly active antiretrovirus therapy","volume":"28","author":"Morooka","year":"2010","journal-title":"Jpn J Radiol"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib64","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1200\/JCO.1997.15.9.3085","article-title":"AIDS-related Kaposi's sarcoma: Prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee","volume":"15","author":"Krown","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib65","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood.V95.4.1406.004k26_1406_1412","article-title":"HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma","volume":"95","author":"Dupin","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib66","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s00259-008-0998-4","article-title":"FDG-PET\/CT imaging in the management of HIV-associated multicentric Castleman's disease","volume":"36","author":"Barker","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib67","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","article-title":"Trends in cancer risk among people with AIDS in the United States 1980\u20132002","volume":"20","author":"Engels","year":"2006","journal-title":"AIDS"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib68","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/cncr.21562","article-title":"Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy","volume":"106","author":"Diamond","year":"2005","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib69","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/01.qai.0000371677.48743.8d","article-title":"Immunologic and virologic predictors of AIDS-related non-Hodgkin lymphoma in the highly active antiretroviral therapy era","volume":"54","author":"Engels","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib70","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S1470-2045(09)70282-7","article-title":"Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): A prospective cohort study","volume":"10","author":"Guiguet","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib71","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/599313","article-title":"Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma","volume":"200","author":"Zoufaly","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib72","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1182\/blood-2010-03-275917","article-title":"AIDS-related Burkitt lymphoma in the United States: What do age and CD4 lymphocyte patterns tell us about etiology and\/or biology?","volume":"116","author":"Guech-Ongey","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib73","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0002-9343(01)01020-8","article-title":"Human immunodeficiency virus-related lymphoma: Relation between clinical features and histologic subtypes","volume":"111","author":"Gabarre","year":"2001","journal-title":"Am J Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib74","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0889-8588(05)70388-9","article-title":"Biology and management of AIDS-associated primary CNS lymphomas","volume":"10","author":"Forsyth","year":"1996","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib75","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/sj.bjc.6605756","article-title":"Changing patterns of cancer incidence in the early- and late-HAART periods: The Swiss HIV Cohort Study","volume":"103","author":"Franceschi","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib76","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s12149-011-0506-y","article-title":"Demonstrations of AIDS-associated malignancies and infections at FDG PET-CT","volume":"25","author":"Liu","year":"2011","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib77","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/RLU.0b013e3181813047","article-title":"PET\/CT in the evaluation of lymphoma in patients with HIV-1 with suppressed viral loads","volume":"33","author":"Goshen","year":"2008","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib78","first-page":"698","article-title":"FDG uptake in lymph-nodes of HIV+ and tuberculosis patients: Implications for cancer staging","volume":"54","author":"Sathekge","year":"2010","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib79","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/apc.2008.0174","article-title":"18F-fluorodeoxyglucose positron emission tomography\/computed tomography in AIDS-related Burkitt lymphoma","volume":"22","author":"Just","year":"2008","journal-title":"Aids Patient Care STDS"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib80","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s11899-012-0125-2","article-title":"Hodgkin lymphoma in patients with HIV infection: A review","volume":"7","author":"Martis","year":"2012","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib81","first-page":"567","article-title":"FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS","volume":"34","author":"Hoffman","year":"1993","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib82","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/00004728-199507000-00004","article-title":"Differential diagnosis of CNS lesions in AIDS patients by FDG-PET","volume":"19","author":"Villringer","year":"1995","journal-title":"J Comput Assist Tomogr"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib83","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1258\/0956462961918239","article-title":"Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET)","volume":"7","author":"Heald","year":"1996","journal-title":"Int J STD AIDS"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib84","first-page":"1575","article-title":"PET scanning and the human immunodeficiency virus-positive patient","volume":"38","author":"O'Doherty","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib85","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11065-009-9102-5","article-title":"Cognitive neuropsychology of HIV-associated neurocognitive disorders","volume":"19","author":"Woods","year":"2009","journal-title":"Neuropsychol Rev"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib86","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1148\/radiol.2451060731","article-title":"Molecular neuroimaging: From conventional to emerging techniques1","volume":"24","author":"Hammoud","year":"2007","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib87","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/1570162043485095","article-title":"Advances in neuroimaging for HIV-1 associated neurological dysfunction: Clues to the diagnosis, pathogenesis and therapeutic monitoring","volume":"2","author":"Boska","year":"2004","journal-title":"Curr HIV Res"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib88","first-page":"2169","article-title":"Functional brain imaging in HIV-1-infected children born to seropositive mothers","volume":"36","author":"Depas","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib89","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1176\/jnp.7.2.180","article-title":"Cerebral metabolic change in patients with AIDS: Report of a six-month follow-up using positron-emission tomography","volume":"7","author":"Hinkin","year":"1995","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib90","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1176\/jnp.5.3.316","article-title":"EEG coherence in men with AIDS: Association with subcortical metabolic activity","volume":"5","author":"Newton","year":"1993","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib91","first-page":"1133","article-title":"Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia","volume":"37","author":"Rottenberg","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib92","first-page":"1177","article-title":"Peptide T and glucose metabolism in AIDS dementia complex","volume":"37","author":"Villemagne","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib93","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1001\/archneur.57.11.1601","article-title":"Potential time course of human immunodeficiency virus type 1-associated minor motor deficits: Electrophysiologic and positron emission tomography findings","volume":"57","author":"von Giesen","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib94","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/ana.410220605","article-title":"The metabolic pathology of the AIDS dementia complex","volume":"22","author":"Rottenberg","year":"1987","journal-title":"Ann Neurol"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib95","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1176\/jnp.4.3.280","article-title":"Cerebral metabolic dysfunction in AIDS: Findings in a sample with and without dementia","volume":"4","author":"Van Gorp","year":"1992","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib96","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/QAD.0b013e328306a6c5","article-title":"Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study","volume":"22","author":"Kingsley","year":"2008","journal-title":"AIDS"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib97","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/COH.0b013e328329c62f","article-title":"The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: Shifting paradigms","volume":"4","author":"Baker","year":"2009","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib98","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMe078037","article-title":"Cardiovascular risks of antiretroviral therapy","volume":"356","author":"Stein","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib99","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.nucmedbio.2007.07.001","article-title":"Clinical use of FDG PET","volume":"34","author":"Hoh","year":"2007","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/snuc.2002.29278","article-title":"18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation","volume":"32","author":"Hongming","year":"2002","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib101","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2967\/jnumed.108.056325","article-title":"One step closer to imaging vulnerable plaque in the coronary arteries","volume":"50","author":"Fox","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib102","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1476-9255-9-26","article-title":"18FDG PET-CT imaging detects arterial inflammation and early atherosclerosis in HIV-infected adults with cardiovascular disease risk factors","volume":"9","author":"Yarasheski","year":"2012","journal-title":"J Inflamm (Lond)"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib103","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2012.6698","article-title":"Arterial inflammation in patients with HIV","volume":"308","author":"Subramanian","year":"2012","journal-title":"J Am Med Assoc"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib104","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction and natural course of HIV-1 protease inhibitor-associated lipodystrophy, hyperlipidemaemia, and diabetes mellitus: A cohort study","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib105","doi-asserted-by":"crossref","unstructured":"Behrens G, Stoll M, Schmidt R: Lipdosystrophy syndrome in HIV infection: What is it, what causes it and how can it be managed? Drug Saf 2000; 23: 57-76","DOI":"10.2165\/00002018-200023010-00004"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib106","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1172\/JCI200215626","article-title":"Impaired glucose phosphorylation and transport in skeletal muscle cause insulin resistance in HIV-1-infected patients with lipodystrophy","volume":"110","author":"Behrens","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib107","first-page":"2430","article-title":"F-18-Fluorodexoyglucose positron emission tomography for visualization of lipodystrophy in HIV-infected patients","volume":"18","author":"Bleeker-Rovers","year":"2004","journal-title":"AIDS"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib108","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/MNM.0b013e3283359058","article-title":"Evaluation of glucose uptake by skeletal muscle tissue and subcutaneous fat in HIV-infected patients with and without lipodystrophy using FDG-PET","volume":"31","author":"Sathekge","year":"2010","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib109","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.transci.2011.01.014","article-title":"PET\/CT scanning with a high HIV\/AIDS prevalence","volume":"44","author":"Warwick","year":"2011","journal-title":"Transfus Apher Sci"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/QAD.0b013e3282f2589b","article-title":"The role of the thymus in HIV infection: A 10 year perspective","volume":"22","author":"Tsong Fang","year":"2008","journal-title":"AIDS"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib111","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1468-1293.2004.00187.x","article-title":"Evidence of thymic reconstitution after highly active antiretroviral therapy in HIV-1 infection","volume":"5","author":"Hardy","year":"2004","journal-title":"HIV Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib112","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/QAD.0b013e3283474155","article-title":"Thymic tissue is not evident on high-resolution computed tomography and [18F]fluoro-deoxy-glucose positron emission tomography scans of aviraemic HIV patients with poor recovery of CD4+ T cells","volume":"25","author":"Tanaskovic","year":"2011","journal-title":"AIDS"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib113","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00002030-199903110-00003","article-title":"Acute upregulation of CCR-5 expression by CD4+ T lymphocytes in HIV-infected patients treated with interleukin-2","volume":"13","author":"Zou","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib114","series-title":"Global Tuberculosis Control Report. Surveillance Planning Financing","year":"2009"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MNM.0b013e3283441382","article-title":"Can positron emission tomography work in the African tuberculosis epidemic?","volume":"32","author":"Sathekge","year":"2011","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib116","series-title":"Report on the Global AIDS Epidemic","year":"2008"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib117","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/bmb\/ldm009","article-title":"Diagnosing tuberculosis in HIV-infected patients: Challenges and future prospects","volume":"81-82","author":"Mendelson","year":"2007","journal-title":"Br Med Bull"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib118","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.2174\/138161211797470183","article-title":"Positron emission tomography in the diagnosis and treatment management of tuberculosis","volume":"17","author":"Kosterink","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib119","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/snuc.2002.29278","article-title":"18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation","volume":"32","author":"Zhuang","year":"2002","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib120","first-page":"871","article-title":"Dual point 18FFDG PET for the evaluation of pulmonary nodules","volume":"43","author":"Matthies","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib121","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1148\/radiology.216.1.r00jl19117","article-title":"Pulmonary tuberculoma evaluated by means of FDG PET: Findings in 10 cases","volume":"216","author":"Goo","year":"2000","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib122","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00259-007-0585-0","article-title":"Double-phase 18F-FDG PET-CT for determination of pulmonary tuberculoma activity","volume":"35","author":"Kim","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib123","series-title":"Pathology","first-page":"31","article-title":"Inflammation and repair","author":"Cameron","year":"1967"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib124","first-page":"161","article-title":"The granulomatous inflammatory response: A review","volume":"84","author":"Adams","year":"1976","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib125","series-title":"Fishman's Pulmonary Disease and Disorders","first-page":"2447","article-title":"Pathogenesis of pulmonary tuberculosis","author":"Dannenberg","year":"1998"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib126","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1183\/09031936.93.03091015","article-title":"Effects of anaerobosis upon morphology and energy metabolism of alveloar macrophages cultured in gas phase","volume":"3","author":"Cazin","year":"1990","journal-title":"Eur Respir J"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib127","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1378\/chest.124.3.893","article-title":"Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis","volume":"124","author":"Hara","year":"2003","journal-title":"Chest"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib128","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.crad.2008.01.003","article-title":"The value of dual time point 18F-FDG PET imaging for the differentiation between malignant and benign lesions","volume":"63","author":"Lan","year":"2008","journal-title":"Clin Radiol"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib129","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2214\/AJR.07.3457","article-title":"Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5","volume":"191","author":"Chen","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib130","doi-asserted-by":"crossref","first-page":"598","DOI":"10.7196\/SAMJ.4082","article-title":"Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area","volume":"100","author":"Sathekge","year":"2010","journal-title":"S Afr Med J"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib131","unstructured":"WHO (World Health Organization): Global Tuberculosis Control: WHO Report. Geneva, 2011. http:\/\/www.who.int\/tb\/publications\/global_report\/en\/"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib132","unstructured":"WHO (World Health Organization): Global Tuberculosis Control: surveillance, Planning, Financing. WHO Report, Geneva, 2007. http:\/\/www.who.int\/tb\/publications\/global_report\/2007\/ pdf\/full.pdf"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib133","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/605559","article-title":"Epidemiology of extrapulmonary tuberculosis in the United States, 1993\u20132006","volume":"49","author":"Peto","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib134","first-page":"316","article-title":"Extrapulmonary tuberculosis","volume":"120","author":"Sharma","year":"2004","journal-title":"Indian J Med Res"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.7705\/biomedica.v26i1.1396","article-title":"Extrapulmonary tuberculosis: A review of 102 cases in Pereira, Colombia","volume":"26","author":"Arciniegas","year":"2006","journal-title":"Biomedica"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib136","first-page":"1761","article-title":"Extrapulmonary tuberculosis: An overview","volume":"72","author":"Golden","year":"2005","journal-title":"Am Fam Physician"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib137","article-title":"Imaging findings of Pott's disease","author":"Rivas-Garcia","year":"2012","journal-title":"Eur Spine J"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib138","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3413\/nukmed-0270","article-title":"Impact of FDG PET on the management of TBC treatment. A pilot study","volume":"49","author":"Sathekge","year":"2010","journal-title":"Nuklearmedizin"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2967\/jnumed.110.083709","article-title":"Use of 18F-FDG PET to predict response to first-line tuberculostatics in HIV-associated tuberculosis","volume":"52","author":"Sathekge","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib140","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1128\/AAC.00789-09","article-title":"Noninvasive pulmonary [18F]-2-fluoro-deoxy-d-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment","volume":"53","author":"Davis","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib141","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00259-008-1009-5","article-title":"Usefulness of 18F-fluorodeoxyglucose positron emission tomography for diagnosing disease activity and monitoring therapeutic response in patients with pulmonary mycobacteriosis","volume":"36","author":"Demura","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/RLU.0b013e31815c5128","article-title":"Evaluation of therapeutic response of tuberculoma using F-18 FDG positron emission tomography","volume":"33","author":"Park","year":"2008","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib143","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3109\/02841851.2010.504744","article-title":"FDG PET\/CT for therapeutic response monitoring in multi-site non-respiratory tuberculosis","volume":"51","author":"Tian","year":"2010","journal-title":"Acta Radiol"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib144","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.tube.2007.05.013","article-title":"Mycobacterium tuberculosis infection in patients with cancer, the role of 18-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring treatment response","volume":"87","author":"Hofmeyr","year":"2007","journal-title":"Tuberculosis"},{"key":"10.1053\/j.semnuclmed.2013.04.008_bib145","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s00259-012-2115-y","article-title":"Tuberculous lymphadenitis: FDG PET and CT findings in responsive and nonresponsive disease","volume":"39","author":"Sathekge","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299813000433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299813000433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T16:23:24Z","timestamp":1715790204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299813000433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":145,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0001299813000433"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2013.04.008","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}